APLP2 Recombinant Antibody, PE-Cy7 Conjugated
Product Specifications
Background
May play a role in the regulation of hemostasis. The soluble form may have inhibitory properties towards coagulation factors. May interact with cellular G-protein signaling pathways. May bind to the DNA 5'-GTCACATG-3' (CDEI box) . Inhibits trypsin, chymotrypsin, plasmin, factor XIA and plasma and glandular kallikrein. Modulates the Cu/Zn nitric oxide-catalyzed autodegradation of GPC1 heparan sulfate side chains in fibroblasts.
Synonyms
Aplp2; APPH; APPL2; CDEBP.
Gene ID
334
Swiss Prot
Q06481
Cellular Locus
Nucleus, Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
APLP2
Clonality
Recombinant
Isotype
IgG
Conjugation
PE-Cy7
Source
KLH conjugated synthetic peptide derived from human APLP2
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/780nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
334
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
P3130-40-ML405 100 µL
PECI, CT (Peroxisomal 3,2-trans-enoyl-CoA Isomerase, ACBD2, Delta (3), delta (2) -enoyl-CoA Isomerase, D3, D2-enoyl-CoA Isomerase, Diazepam-binding Inhibitor-related Protein 1, DBI-related Protein 1, dJ1013A10.3, Dodecenoyl-CoA Isomerase, DRS1, DRS-1, Hepatocellular Carcinoma-associated Antigen 88, HCA88, KIAA0536, Renal Carcinoma Antigen NY-REN-1) (MaxLight 405) discontinued
Ask
View Details 
GTR15299665 1 Vial
Lentiviral human TMEM92 shRNA (UAS) - Lentiviral human TMEM92 shRNA (UAS, GFP) plasmid
Ask
View Details